131 related articles for article (PubMed ID: 11366454)
1. Amprenavir, new protease inhibitor, approved.
James JS
AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
[TBL] [Abstract][Full Text] [Related]
2. Drug approval.
AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
[TBL] [Abstract][Full Text] [Related]
3. Amprenavir (Agenerase).
Simmons P
Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
[TBL] [Abstract][Full Text] [Related]
4. Amprenavir approved.
STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
[TBL] [Abstract][Full Text] [Related]
5. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
Highleyman L
BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
[TBL] [Abstract][Full Text] [Related]
6. Study: new drug doesn't display cross-resistance.
AIDS Alert; 1999 Jul; 14(7):77. PubMed ID: 11366418
[TBL] [Abstract][Full Text] [Related]
7. Amprenavir (Agenerase) now available in expanded access.
AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864
[TBL] [Abstract][Full Text] [Related]
8. Amprenavir: a new protease inhibitor nears approval.
Highleyman L
BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
[TBL] [Abstract][Full Text] [Related]
9. New protease inhibitor.
Vazquez E
Posit Aware; 1999; 10(3):24. PubMed ID: 11366764
[TBL] [Abstract][Full Text] [Related]
10. Glaxo Wellcome's two new drugs.
Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
[TBL] [Abstract][Full Text] [Related]
11. Amprenavir: a new human immunodeficiency virus type 1 protease inhibitor.
Fung HB; Kirschenbaum HL; Hameed R
Clin Ther; 2000 May; 22(5):549-72. PubMed ID: 10868554
[TBL] [Abstract][Full Text] [Related]
12. FDA approves an AIDS drug from Vertex. Food and Drug Administration.
Newsline People AIDS Coalit N Y; 1999; ():32. PubMed ID: 11367345
[TBL] [Abstract][Full Text] [Related]
13. Coming therapies: amprenavir.
Gatell J
Int J Clin Pract Suppl; 1999 Jun; 103():42-4. PubMed ID: 10622044
[TBL] [Abstract][Full Text] [Related]
14. Amprenavir: new preparation. Another HIV protease inhibitor: no proven advance.
Prescrire Int; 2001 Jun; 10(53):70-2. PubMed ID: 11718166
[TBL] [Abstract][Full Text] [Related]
15. Agenerase approved by FDA.
Gaylord G
Posit Living; 1999 May; 8(4):6. PubMed ID: 12492061
[No Abstract] [Full Text] [Related]
16. Amprenavir: a new HIV protease inhibitor.
Med Lett Drugs Ther; 1999 Jul; 41(1057):64-6. PubMed ID: 10436772
[No Abstract] [Full Text] [Related]
17. Nelfinavir: fourth protease inhibitor approved.
Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
[TBL] [Abstract][Full Text] [Related]
18. HIV protease mutations associated with amprenavir resistance during salvage therapy: importance of I54M.
Murphy MD; Marousek GI; Chou S
J Clin Virol; 2004 May; 30(1):62-7. PubMed ID: 15072756
[TBL] [Abstract][Full Text] [Related]
19. Amprenavir (Vertex Pharmaceuticals Inc).
Billich A
IDrugs; 1999 May; 2(5):466-82. PubMed ID: 16155850
[TBL] [Abstract][Full Text] [Related]
20. Amprenavir approved.
AIDS Patient Care STDS; 1999 Jul; 13(7):438. PubMed ID: 10870601
[No Abstract] [Full Text] [Related]
[Next] [New Search]
